To verify IGF2BP1 targets in HCC, we examined selected IGF2BP1 targets by western blotting and found that c-Myc, MDR1, PTEN, and IGF2 were downregulated in response to IGF2BP1 overexpression or expression knockdown (Fig. S9C, D). This evidence concerns the gene IGF2 and hepatocellular carcinoma.